2021-01-07,Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference
2020-12-07,"Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option"
2020-12-07,"Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option"
2020-12-03,Achieve Life Sciences Announces Pricing of $15 Million Public Offering
2020-12-03,Achieve Life Sciences Announces Pricing of $15 Million Public Offering
2020-11-30,Achieve Life Sciences Announces Proposed Public Offering
2020-11-30,Achieve Life Sciences Announces Proposed Public Offering
2020-11-30,ACHV: The ORCA Has Launched: Target to $50
2020-11-24,ACHV: Achieve Hosts Smoking Cessation KOL Call
2020-11-16,Is Achieve Life Sciences (NASDAQ:ACHV) In A Good Position To Invest In Growth?
2020-11-12,Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update
2020-11-12,Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update
2020-11-12,"Achieve Life Sciences, Inc. to Host Earnings Call"
2020-10-29,"Achieve Life Sciences to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020"
2020-10-27,"Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual Roundtable on November 17th, 2020"
2020-10-08,"Achieve Life Sciences Announces to Present at the MicroCap Best Ideas Conference, October 13, 2020"
2020-10-07,Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline for Smoking Cessation
2020-09-30,Achieve Life Sciences Announces Appointment of John Bencich to Chief Executive Officer & Dr. Cindy Jacobs to President
2020-09-30,Achieve Life Sciences Announces Appointment of John Bencich to Chief Executive Officer & Dr. Cindy Jacobs to President
2020-09-21,ACHV: Achieve Updates and RAUORA
2020-09-18,Achieve Announces Presentation of Investigator-Led RAUORA Trial Data Demonstrating Significantly Fewer Side Effects with Higher Quit Rates for Cytisinicline (cytisine) Compared to Chantix速 (varenicline) in First Head-to-Head Comparative Study
2020-09-18,Achieve Life Sciences Announces Results from Evaluation of Cytisinicline (cytisine) versus Chantix速 (varenicline) in 5-HT3 Receptor Binding Assay Study
2020-09-10,Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 20th Annual Society for Research on Nicotine & Tobacco Europe (SRNT-E) Virtual Conference
2020-09-03,Achieve Life Sciences to Present at Upcoming Investor Conferences
2020-08-24,ACHV: Fourth Quarter Start for ORCA-2
2020-08-06,Achieve Reports Financial Results for Second Quarter 2020 and Provides Update on Cytisinicline Development Program
2020-06-30,ACHV: RAUORA: Cytisiniclines Superior Side Effect Profile
2020-06-29,Achieve Life Sciences Announces Pricing of $6 Million Registered Direct Offering
2020-06-29,Achieve Life Sciences Announces Pricing of $6 Million Registered Direct Offering
2020-06-29,Achieve Announces Successful Results from the Investigator-Initiated RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix速 (varenicline) as a Treatment to Quit Smoking
2020-06-29,Achieve Announces Successful Results from the Investigator-Initiated RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix速 (varenicline) as a Treatment to Quit Smoking
2020-06-05,"Hedge Funds Nibbling On Achieve Life Sciences, Inc. (ACHV)"
2020-05-29,ACHV: When Quitting Gets You to the Finish Line
2020-05-14,Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development Program
2020-05-05,"Achieve Life Sciences to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 14, 2020"
2020-04-30,Achieve Life Sciences Announces Private Placement of $1.9 Million
2020-04-06,ACHV: Extended Treatment May Improve Quit Rates
2020-04-02,"Seasoned Biotech Financial Executive, Jay M. Moyes, Joins Sera Prognostics"
2020-03-13,Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program
2020-03-13,Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program
2020-03-12,Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting
2020-03-03,"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2019 Financial Results and Host Conference Call and Webcast on March 13, 2020"
2020-02-06,Achieve Life Sciences Announces Agreement with the FreeMind Group to Assist in Securing Non-Dilutive Funding to Evaluate Cytisinicline in Vaping and e-Cigarette Users
2020-01-13,"Achieve Life Sciences, University of Bristol, and Oracle Corporation Announce Study Results Demonstrating Potential for Accelerated Speed of Drug Discovery"
2019-12-23,Here's Why We're A Bit Worried About Achieve Life Sciences's (NASDAQ:ACHV) Cash Burn Situation
2019-12-19,"Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option"
2019-12-19,"Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option"
2019-12-17,Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
2019-12-17,Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
2019-12-09,Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program
2019-12-09,Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program
2019-11-11,ACHV: After Capital Raise Ready for Phase III
2019-11-06,Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program
2019-11-06,Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program
2019-10-31,"Achieve Life Sciences to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 6, 2019"
2019-10-24,"What Type Of Shareholder Owns Achieve Life Sciences, Inc.'s (NASDAQ:ACHV)?"
2019-10-24,Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference
2019-10-24,Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference
2019-09-30,Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study
2019-09-25,ACHV: Post Phase II Investor Day
2019-09-13,Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
2019-09-09,"What Kind Of Share Price Volatility Should You Expect For Achieve Life Sciences, Inc. (NASDAQ:ACHV)?"
2019-09-05,Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial
2019-09-04,Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences
2019-08-26,ACHV: SRNT Presentation Next on Agenda
2019-08-26,ACHV: SRNT Presentation Next on Agenda
2019-08-08,"/C O R R E C T I O N -- Achieve Life Sciences, Inc./"
2019-08-08,Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update
2019-07-30,"Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019"
2019-07-30,"Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019"
2019-07-23,Achieve Life Sciences Extends Collaboration with the National Institutes of Health to Advance the Development of Cytisinicline for Smoking Cessation
2019-07-10,Did You Manage To Avoid Achieve Life Sciences's (NASDAQ:ACHV) Painful 55% Share Price Drop?
2019-06-21,Achieve Life Sciences Says Mid-Stage Data For Smoking Cessation Drug Accepted For Presentation At Conference
2019-06-21,Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
2019-06-12,ACHV: ORCA-1 Topline Results and Comparison
2019-06-11,Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial
2019-06-11,Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial
2019-06-03,Achieve Receives $4.2 Million from Exercise of Warrants
2019-06-03,Achieve Receives $4.2 Million from Exercise of Warrants
2019-05-30,ACHV: 1Q:19 Financial & Operational Update
2019-05-30,Achieve Announces Patent Granted in the U.S. for Novel Formulation of Cytisinicline
2019-05-15,Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update
2019-05-15,Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update
2019-05-07,"Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019"
2019-04-26,"ACHV: Final Enrollee, Final Visit"
2019-04-24,"Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation"
2019-04-03,"Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019"
2019-04-02,"The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial"
2019-04-02,Achieve Life Sciences Announces Successful Completion of the Second and Final DSMC Review of Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation
2019-03-25,ACHV: Fiscal Year 2018 Operational and Financial Results
2019-03-18,What Do the Clinical Updates at Achieve Life Sciences Mean for Cytisinicline
2019-03-18,"Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019"
2019-03-15,Four Healthcare Stocks Picking Up Speed On Friday
2019-03-14,Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update
2019-03-12,ACHV: A Reason to Quit is a Reason to Buy
2019-03-05,"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019"
2019-02-28,Predictive Technology Group Names Jay M. Moyes to Its Board of Directors
2019-02-25,Healthcare Stocks Leading the Sector
2019-02-25,"Could The Achieve Life Sciences, Inc. (NASDAQ:ACHV) Ownership Structure Tell Us Something Useful?"
2019-02-22,Four Healthcare Stocks Looking to Close Out a Strong Week
